File(s) under permanent embargo
Anti-inflammatory effects of lenabasum, a cannabinoid receptor type 2 agonist, on macrophages from cystic fibrosis
Version 2 2024-06-13, 15:15
Version 1 2022-03-18, 08:34
journal contribution
posted on 2024-06-13, 15:15 authored by AA Tarique, T Evron, G Zhang, MA Tepper, MM Morshed, ISG Andersen, N Begum, PD Sly, E FantinoAnti-inflammatory effects of lenabasum, a cannabinoid receptor type 2 agonist, on macrophages from cystic fibrosis
History
Journal
Journal of Cystic FibrosisVolume
19Pagination
823-829Location
Amsterdam, The NetherlandsPublisher DOI
ISSN
1569-1993eISSN
1873-5010Language
EnglishPublication classification
C1 Refereed article in a scholarly journalIssue
5Publisher
ElsevierUsage metrics
Keywords
ACTIVATIONAnti-inflammatoryCA2+Cannabinoid 2 receptor (CB2)CB2 agonistsCELLSCHILDRENCystic fibrosisEndocytosisINFANTSINFLAMMATIONLife Sciences & BiomedicineLUNG-DISEASEMacrophage polarizationMacrophage responsesPhagocytosisRECRUITED MONOCYTESRespiratory SystemScience & Technology3204 Immunology3213 Paediatrics
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC